Industry: Chemical & Material
Published Date: 2024-01-16
Pages: 96 Pages
Report ld: 2237262
Request Sample
Customized Report
Ioversol is an organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (X-ray) examination. This unique property of ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the heart, brain, and blood vessels.
Rise in number of accidents and increase in prevalence of bone-related diseases & kidney problems are the key drivers of the global ioversol market. In addition, growth in geriatric population has led to increased orthopedic disorders and cardiovascular disorders, resulting in the development of the X-ray industry, which in turn fuels the market growth. However, overdose of ioversol might lead allergic reaction; breathing problem; swelling of the face, lips, tongue, or throat; and dehydration & dry skin, which restrains the market growth. Increase in spending on healthcare and advancements in X-ray, CT scan, and other radiological & diagnostic examinations are anticipated to provide new opportunities for the market players.
The global Ioversol market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ioversol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ioversol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ioversol include Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject, China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd and Stellence Pharmscience Pvt. Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ioversol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ioversol.
MARKET SEGMENTATION
REPORT SCOPE
The Ioversol market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ioversol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ioversol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ioversol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Ioversol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Ioversol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Ioversol Market Overview
1.1 Product Definition
1.2 Ioversol Segment by Type
1.2.1 Global Ioversol Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Ioversol 34% Injectable Solution (Optiray 160)
1.2.3 Ioversol 51% Injectable Solution (Optiray 240)
1.2.4 Ioversol 64% Injectable Solution (Optiray 300)
1.2.5 Ioversol 68% Injectable Solution (Optiray 320)
1.2.6 Ioversol 74% Injectable Solution (Optiray 350)
1.3 Ioversol Segment by Application
1.3.1 Global Ioversol Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 X-ray
1.3.3 CT Scan
1.3.4 Brain Disorders
1.3.5 Blood Vessel Disorders
1.3.6 Heart Disorders
1.3.7 Others
1.4 Global Market Growth Prospects
1.4.1 Global Ioversol Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Ioversol Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Ioversol Production Estimates and Forecasts (2019-2030)
1.4.4 Global Ioversol Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Ioversol Production Market Share by Manufacturers (2019-2024)
2.2 Global Ioversol Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Ioversol, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Ioversol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Ioversol Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Ioversol, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ioversol, Product Offered and Application
2.8 Global Key Manufacturers of Ioversol, Date of Enter into This Industry
2.9 Ioversol Market Competitive Situation and Trends
2.9.1 Ioversol Market Concentration Rate
2.9.2 Global 5 and 10 Largest Ioversol Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Ioversol Production by Region
3.1 Global Ioversol Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Ioversol Production Value by Region (2019-2030)
3.2.1 Global Ioversol Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Ioversol by Region (2025-2030)
3.3 Global Ioversol Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Ioversol Production by Region (2019-2030)
3.4.1 Global Ioversol Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Ioversol by Region (2025-2030)
3.5 Global Ioversol Market Price Analysis by Region (2019-2024)
3.6 Global Ioversol Production and Value, Year-over-Year Growth
3.6.1 North America Ioversol Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Ioversol Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Ioversol Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Ioversol Production Value Estimates and Forecasts (2019-2030)
4 Ioversol Consumption by Region
4.1 Global Ioversol Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Ioversol Consumption by Region (2019-2030)
4.2.1 Global Ioversol Consumption by Region (2019-2024)
4.2.2 Global Ioversol Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Ioversol Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Ioversol Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ioversol Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Ioversol Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ioversol Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Ioversol Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ioversol Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Ioversol Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Ioversol Production by Type (2019-2030)
5.1.1 Global Ioversol Production by Type (2019-2024)
5.1.2 Global Ioversol Production by Type (2025-2030)
5.1.3 Global Ioversol Production Market Share by Type (2019-2030)
5.2 Global Ioversol Production Value by Type (2019-2030)
5.2.1 Global Ioversol Production Value by Type (2019-2024)
5.2.2 Global Ioversol Production Value by Type (2025-2030)
5.2.3 Global Ioversol Production Value Market Share by Type (2019-2030)
5.3 Global Ioversol Price by Type (2019-2030)
6 Segment by Application
6.1 Global Ioversol Production by Application (2019-2030)
6.1.1 Global Ioversol Production by Application (2019-2024)
6.1.2 Global Ioversol Production by Application (2025-2030)
6.1.3 Global Ioversol Production Market Share by Application (2019-2030)
6.2 Global Ioversol Production Value by Application (2019-2030)
6.2.1 Global Ioversol Production Value by Application (2019-2024)
6.2.2 Global Ioversol Production Value by Application (2025-2030)
6.2.3 Global Ioversol Production Value Market Share by Application (2019-2030)
6.3 Global Ioversol Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Liebel-Flarsheim Company LLC
7.1.1 Liebel-Flarsheim Company LLC Ioversol Corporation Information
7.1.2 Liebel-Flarsheim Company LLC Ioversol Product Portfolio
7.1.3 Liebel-Flarsheim Company LLC Ioversol Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Liebel-Flarsheim Company LLC Main Business and Markets Served
7.1.5 Liebel-Flarsheim Company LLC Recent Developments/Updates
7.2 Guerbet
7.2.1 Guerbet Ioversol Corporation Information
7.2.2 Guerbet Ioversol Product Portfolio
7.2.3 Guerbet Ioversol Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Guerbet Main Business and Markets Served
7.2.5 Guerbet Recent Developments/Updates
7.3 Jiangsu Hengrui Medicine Co
7.3.1 Jiangsu Hengrui Medicine Co Ioversol Corporation Information
7.3.2 Jiangsu Hengrui Medicine Co Ioversol Product Portfolio
7.3.3 Jiangsu Hengrui Medicine Co Ioversol Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Jiangsu Hengrui Medicine Co Main Business and Markets Served
7.3.5 Jiangsu Hengrui Medicine Co Recent Developments/Updates
7.4 Mallinckrodt Pharmaceuticals
7.4.1 Mallinckrodt Pharmaceuticals Ioversol Corporation Information
7.4.2 Mallinckrodt Pharmaceuticals Ioversol Product Portfolio
7.4.3 Mallinckrodt Pharmaceuticals Ioversol Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Mallinckrodt Pharmaceuticals Main Business and Markets Served
7.4.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.5 Ultraject
7.5.1 Ultraject Ioversol Corporation Information
7.5.2 Ultraject Ioversol Product Portfolio
7.5.3 Ultraject Ioversol Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Ultraject Main Business and Markets Served
7.5.5 Ultraject Recent Developments/Updates
7.6 China Resources Pharmaceutical (Shanghai) Co
7.6.1 China Resources Pharmaceutical (Shanghai) Co Ioversol Corporation Information
7.6.2 China Resources Pharmaceutical (Shanghai) Co Ioversol Product Portfolio
7.6.3 China Resources Pharmaceutical (Shanghai) Co Ioversol Production, Value, Price and Gross Margin (2019-2024)
7.6.4 China Resources Pharmaceutical (Shanghai) Co Main Business and Markets Served
7.6.5 China Resources Pharmaceutical (Shanghai) Co Recent Developments/Updates
7.7 HB Ocean
7.7.1 HB Ocean Ioversol Corporation Information
7.7.2 HB Ocean Ioversol Product Portfolio
7.7.3 HB Ocean Ioversol Production, Value, Price and Gross Margin (2019-2024)
7.7.4 HB Ocean Main Business and Markets Served
7.7.5 HB Ocean Recent Developments/Updates
7.8 Novalek Pharmaceuticals Pvt. Ltd
7.8.1 Novalek Pharmaceuticals Pvt. Ltd Ioversol Corporation Information
7.8.2 Novalek Pharmaceuticals Pvt. Ltd Ioversol Product Portfolio
7.8.3 Novalek Pharmaceuticals Pvt. Ltd Ioversol Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Novalek Pharmaceuticals Pvt. Ltd Main Business and Markets Served
7.7.5 Novalek Pharmaceuticals Pvt. Ltd Recent Developments/Updates
7.9 Stellence Pharmscience Pvt. Ltd
7.9.1 Stellence Pharmscience Pvt. Ltd Ioversol Corporation Information
7.9.2 Stellence Pharmscience Pvt. Ltd Ioversol Product Portfolio
7.9.3 Stellence Pharmscience Pvt. Ltd Ioversol Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Stellence Pharmscience Pvt. Ltd Main Business and Markets Served
7.9.5 Stellence Pharmscience Pvt. Ltd Recent Developments/Updates
7.10 A.S. Joshi & Company
7.10.1 A.S. Joshi & Company Ioversol Corporation Information
7.10.2 A.S. Joshi & Company Ioversol Product Portfolio
7.10.3 A.S. Joshi & Company Ioversol Production, Value, Price and Gross Margin (2019-2024)
7.10.4 A.S. Joshi & Company Main Business and Markets Served
7.10.5 A.S. Joshi & Company Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ioversol Industry Chain Analysis
8.2 Ioversol Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ioversol Production Mode & Process
8.4 Ioversol Sales and Marketing
8.4.1 Ioversol Sales Channels
8.4.2 Ioversol Distributors
8.5 Ioversol Customers
9 Ioversol Market Dynamics
9.1 Ioversol Industry Trends
9.2 Ioversol Market Drivers
9.3 Ioversol Market Challenges
9.4 Ioversol Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Ioversol was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 132
USD 3950.00
(Single User License)
The global Ioversol market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 134
USD 2900.00
(Single User License)
The global Ioversol market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 149
USD 4900.00
(Single User License)
The global Ioversol market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 79
USD 4250.00
(Single User License)
The global market for Ioversol was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 92
USD 2900.00
(Single User License)
The global market for Ioversol was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 104
USD 3950.00
(Single User License)
Ioversol is an organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (X-ray) examination. This unique property of ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the heart, brain, and blood vessels.
Published Date: 2024-04-15
Pages: 109
USD 4900.00
(Single User License)
Ioversol is an organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (X-ray) examination. This unique property of ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the heart, brain, and blood vessels.
Published Date: 2024-01-24
Pages: 126
USD 3950.00
(Single User License)
The global market for Ioversol was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 132
The global Ioversol market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 134
The global Ioversol market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 149
The global Ioversol market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 79
The global market for Ioversol was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 92
The global market for Ioversol was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 104
Ioversol is an organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (X-ray) examination. This unique property of ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the heart, brain, and blood vessels.
Published: 2024-04-15
Pages: 109
Ioversol is an organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (X-ray) examination. This unique property of ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the heart, brain, and blood vessels.
Published: 2024-01-24
Pages: 126
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now